GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹33 Cr | ₹14 Cr | ₹14 Cr | ₹20 Cr | ₹31 Cr |
What is the latest Capital Work in Progress ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹33 Cr |
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹31 Cr |
How is Capital Work in Progress of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹33 Cr | 129.93 | |
| Mar2025 | ₹14 Cr | 2.80 | |
| Mar2024 | ₹14 Cr | -31.42 | |
| Mar2023 | ₹20 Cr | -33.41 | |
| Mar2022 | ₹31 Cr | - | |
Compare Capital Work in Progress of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹44,949.4 Cr | 4.1% | 9.8% | -17.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,993.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 4.1% |
9.8% |
-17.4% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses